919 Tegavivint reduces the immunosuppressive macrophage phenotype in a preclinical co-culture model of the non-small cell lung cancer tumor microenvironment

• Rolf Brekken,
• John Minna,
• Raghav Chandra,
• Josiah Flaming,
• Aiden Nguyen,
• Michael Peyton,
• Amit Das,
• Boning Gao,
• Steven Horrigan

Affiliations

Rolf Brekken

Aff1 grid.267313.20000000094827121Department of PharmacologyUT Southwestern Medical Center Dallas TX USA

John Minna

1UTSW, Dallas, TX, United States

Raghav Chandra

1University of Texas Southwestern Medical Center, Dallas, TX, USA

Josiah Flaming

1University of Texas Southwestern Medical Center, Dallas, TX, USA

Aiden Nguyen

1University of Texas Southwestern Medical Center, Dallas, TX, USA

Michael Peyton

1University of Texas Southwestern Medical Center, Dallas, TX, USA

Amit Das

1University of Texas Southwestern Medical Center, Dallas, TX, USA

Boning Gao

1University of Texas Southwestern Medical Center, Dallas, TX, USA

Steven Horrigan

2Iterion Therapeutics, Houston, TX, USA